PMC:7463108 / 831-1055 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T26171","span":{"begin":6,"end":9},"obj":"Body_part"},{"id":"T51689","span":{"begin":22,"end":26},"obj":"Body_part"},{"id":"T88958","span":{"begin":218,"end":221},"obj":"Body_part"}],"attributes":[{"id":"A43353","pred":"fma_id","subj":"T26171","obj":"http://purl.org/sig/ont/fma/fma278683"},{"id":"A88272","pred":"fma_id","subj":"T51689","obj":"http://purl.org/sig/ont/fma/fma74402"},{"id":"A51720","pred":"fma_id","subj":"T88958","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"idual HIV-1-expressed gene products at the molecular, cellular and systems levels. Furthermore, we review preclinical and clinical studies with a focus on key considerations when addressing questions of whether opioid-HIV in"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T57883","span":{"begin":22,"end":26},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T35359","span":{"begin":144,"end":145},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T81874","span":{"begin":146,"end":151},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"idual HIV-1-expressed gene products at the molecular, cellular and systems levels. Furthermore, we review preclinical and clinical studies with a focus on key considerations when addressing questions of whether opioid-HIV in"}

{"project":"LitCovid-PubTator","denotations":[{"id":"14","span":{"begin":6,"end":11},"obj":"Species"},{"id":"19","span":{"begin":218,"end":221},"obj":"Species"}],"attributes":[{"id":"A14","pred":"tao:has_database_id","subj":"14","obj":"Tax:11676"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:12721"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"idual HIV-1-expressed gene products at the molecular, cellular and systems levels. Furthermore, we review preclinical and clinical studies with a focus on key considerations when addressing questions of whether opioid-HIV in"}